ArticleVaccine2022

RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.

Abhishek Phatarphekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.